DICERNA PHARMACEUTICALS INC - COM (DRNA)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
15,639,615
Share change
+177,736
Total reported value
$128,392,648
Price per share
$8.21
Number of holders
50
Value change
-$6,309,583
Number of buys
28
Number of sells
30

Institutional Holders of DICERNA PHARMACEUTICALS INC - COM (DRNA) as of Q3 2015

As of 30 Sep 2015, DICERNA PHARMACEUTICALS INC - COM (DRNA) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,639,615 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, RTW INVESTMENTS, LLC, Abingworth LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, and TIVERTON ASSET MANAGEMENT LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.